Clinical Trial Update: A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety of sotagliflozin added to insulin in adults with Type 1 diabetes and inadequate glycemic control; study completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Sotagliflozin (sotagliflozin)

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Type 1 Diabetes Mellitus (T1DM), High Level of Sugar (Glucose) in the Blood | Phase 3 | Status: COMPLETED | Results posted: 2019-11-19